187 related articles for article (PubMed ID: 14961557)
1. A novel PTPN11 mutation in LEOPARD syndrome.
Conti E; Dottorini T; Sarkozy A; Tiller GE; Esposito G; Pizzuti A; Dallapiccola B
Hum Mutat; 2003 Jun; 21(6):654. PubMed ID: 14961557
[TBL] [Abstract][Full Text] [Related]
2. PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes.
Ogata T; Yoshida R
Pediatr Endocrinol Rev; 2005 Jun; 2(4):669-74. PubMed ID: 16208280
[TBL] [Abstract][Full Text] [Related]
3. [PTPN11 gene mutation in LEOPARD syndrome].
Paradisi M; Pedicelli C; Ciasulli A; Pinto F; Conti E; Sarkozy A; Angelo C
Minerva Pediatr; 2005 Aug; 57(4):189-93. PubMed ID: 16172598
[TBL] [Abstract][Full Text] [Related]
4. Familial aggregation of genetically heterogeneous hypertrophic cardiomyopathy: a boy with LEOPARD syndrome due to PTPN11 mutation and his nonsyndromic father lacking PTPN11 mutations.
Digilio MC; Pacileo G; Sarkozy A; Limongelli G; Conti E; Cerrato F; Marino B; Pizzuti A; Calabrò R; Dallapiccola B
Birth Defects Res A Clin Mol Teratol; 2004 Feb; 70(2):95-8. PubMed ID: 14991917
[TBL] [Abstract][Full Text] [Related]
5. A novel PTPN11 gene mutation in a patient with LEOPARD Syndrome.
Du-Thanh A; Cave H; Bessis D; Puso C; Guilhou JJ; Dereure O
Arch Dermatol; 2007 Sep; 143(9):1210-1. PubMed ID: 17875892
[No Abstract] [Full Text] [Related]
6. PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience.
Keren B; Hadchouel A; Saba S; Sznajer Y; Bonneau D; Leheup B; Boute O; Gaillard D; Lacombe D; Layet V; Marlin S; Mortier G; Toutain A; Beylot C; Baumann C; Verloes A; Cavé H;
J Med Genet; 2004 Nov; 41(11):e117. PubMed ID: 15520399
[No Abstract] [Full Text] [Related]
7. PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13.
Maheshwari M; Belmont J; Fernbach S; Ho T; Molinari L; Yakub I; Yu F; Combes A; Towbin J; Craigen WJ; Gibbs R
Hum Mutat; 2002 Oct; 20(4):298-304. PubMed ID: 12325025
[TBL] [Abstract][Full Text] [Related]
8. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
9. Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive).
Uçar C; Calýskan U; Martini S; Heinritz W
J Pediatr Hematol Oncol; 2006 Mar; 28(3):123-5. PubMed ID: 16679933
[TBL] [Abstract][Full Text] [Related]
10. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.
Tartaglia M; Mehler EL; Goldberg R; Zampino G; Brunner HG; Kremer H; van der Burgt I; Crosby AH; Ion A; Jeffery S; Kalidas K; Patton MA; Kucherlapati RS; Gelb BD
Nat Genet; 2001 Dec; 29(4):465-8. PubMed ID: 11704759
[TBL] [Abstract][Full Text] [Related]
11. Mutation screening of the PTPN11 gene in hypertrophic cardiomyopathy.
Limongelli G; Hawkes L; Calabro R; McKenna WJ; Syrris P
Eur J Med Genet; 2006; 49(5):426-30. PubMed ID: 16488201
[TBL] [Abstract][Full Text] [Related]
12. Multiple granular cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11.
Schrader KA; Nelson TN; De Luca A; Huntsman DG; McGillivray BC
Clin Genet; 2009 Feb; 75(2):185-9. PubMed ID: 19054014
[TBL] [Abstract][Full Text] [Related]
13. PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning.
Schollen E; Matthijs G; Gewillig M; Fryns JP; Legius E
Eur J Hum Genet; 2003 Jan; 11(1):85-8. PubMed ID: 12529711
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlations in Noonan syndrome.
Zenker M; Buheitel G; Rauch R; Koenig R; Bosse K; Kress W; Tietze HU; Doerr HG; Hofbeck M; Singer H; Reis A; Rauch A
J Pediatr; 2004 Mar; 144(3):368-74. PubMed ID: 15001945
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome.
Musante L; Kehl HG; Majewski F; Meinecke P; Schweiger S; Gillessen-Kaesbach G; Wieczorek D; Hinkel GK; Tinschert S; Hoeltzenbein M; Ropers HH; Kalscheuer VM
Eur J Hum Genet; 2003 Feb; 11(2):201-6. PubMed ID: 12634870
[TBL] [Abstract][Full Text] [Related]
16. Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1.
Hanna N; Montagner A; Lee WH; Miteva M; Vidal M; Vidaud M; Parfait B; Raynal P
FEBS Lett; 2006 May; 580(10):2477-82. PubMed ID: 16638574
[TBL] [Abstract][Full Text] [Related]
17. PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects.
Kontaridis MI; Swanson KD; David FS; Barford D; Neel BG
J Biol Chem; 2006 Mar; 281(10):6785-92. PubMed ID: 16377799
[TBL] [Abstract][Full Text] [Related]
18. [LEOPARD syndrome].
Hansen LK; Risby K; Bygum A; Gerdes AM
Ugeskr Laeger; 2009 Jan; 171(4):247. PubMed ID: 19174044
[TBL] [Abstract][Full Text] [Related]
19. Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications.
Lee WH; Raas-Rotschild A; Miteva MA; Bolasco G; Rein A; Gillis D; Vidaud D; Vidaud M; Villoutreix BO; Parfait B
Proteins; 2005 Jan; 58(1):7-13. PubMed ID: 15521065
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
Lee ST; Ki CS; Lee HJ
Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
